Kohlberg Kravis Roberts & Co. L.P. Oyster Point Pharma, Inc. Transaction History

Kohlberg Kravis Roberts & Co. L.P.

  • $1.54 Billion
  • Q4 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
BUY
$13.55 - $26.15 $14.1 Million - $27.2 Million
1,039,622 New
1,039,622 $25.4 Million

Others Institutions Holding OYST

# of Institutions
4
Shares Held
19K
Call Options Held
0
Put Options Held
0
View Full List

About Oyster Point Pharma, Inc.

OYST Quotes by TradingView
  • Ticker OYST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,831,500
  • Description
  • Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...
More about OYST
Track This Portfolio

Track Kohlberg Kravis Roberts & Co. L.P. Portfolio

Follow Kohlberg Kravis Roberts & Co. L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kohlberg Kravis Roberts & Co. L.P., based on Form 13F filings with the SEC.

News

Stay updated on Kohlberg Kravis Roberts & Co. L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email